1 ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
2 Department of Medicine, Section of Infectious Diseases, Hacettepe University School of Medicine, Ankara, Turkey; ESCMID Executive Committee, Basel, Switzerland.
3 Department of Microbiology at the Ramón y Cajal University Hospital, Ramón y Cajal Institute for Health Research (IRYCIS), Division for Research in Microbial Biology and Evolution, CIBERESP, Madrid, Spain.
4 Fondation Hôpital St, Joseph, Paris, France and World Alliance Against Antibiotic Resistance (WAAAR), Creteil, France.
5 European Medicines Agency (EMA), London, UK.
6 Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
7 Brighton and Sussex Medical School, Brighton, UK.
8 Global Commercial Lead, GlaxoSmithKline (GSK), London, UK.
9 Department of Medicine, Radboud University Medical Center and Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
10 European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
12 WHO Regional Office for Europe, UN City, Marmorvej, Copenhagen, Denmark.
13 Center for Disease Dynamics, Economics and Policy, Washington, DC, USA; Princeton University, Princeton, NJ, USA.
14 Scientific Unit on Biological Hazards, European Food Safety Authority (EFSA), Parma, Italy.
15 Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain.
16 Department of Medical Microbiology, Southmead Hospital, Bristol, UK; EUCAST Steering Committee, Växjö, Sweden.
17 School of Public Health, Physiotherapy and Population Science, UCD Centre for Food and Safety, Molecular Innovation and Drug Discovery, University College Dublin, Dublin, Ireland.
18 Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, and Departamento de Medicina, Universidad de Sevilla, Seville, Spain; ESCMID Executive Committee, Basel, Switzerland.
19 Aix-Marseille Université, Unité de Recherche en Maladies Infectieuses et Tropicales Emergentes (URMITE), Inserm, IHU Méditerranée Infection, Faculté de Médecine et de Pharmacie, and APHM, CHU Timone, Pôle Infectieux, Marseille, France.
20 Instituto de Salud Carlos III, ISCIII, Madrid, Spain.
21 Centro de Investigação em Saúde da Manhiça and Instituto Nacional de Saúde/Ministério de Saúde, Maputo, Mozambique.
22 Division of Infectious Diseases, Department of Internal Medicine I, Tübingen University Hospital, Tübingen, Germany; ESCMID Executive Committee, Basel, Switzerland.
23 School of Life Sciences, University of Warwick, Coventry, UK.
24 ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain; ESCMID Executive Committee, Basel, Switzerland.